Key facts
- This page summarizes Glenn Krinsky's Form 3 filing for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 06 Apr 2022, 21:58.
Glenn Krinsky - 17 Dec 2021 Form 3 Insider Report for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- LIXT
- Reported as of
- 17 Dec 2021
- Net transaction value
- $0
- Reporting owner signature
- /S/ Glenn Krinsky
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Glenn Krinsky filed Form 3 for LIXTE BIOTECHNOLOGY HOLDINGS, INC. (LIXT) on 06 Apr 2022.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
LIXT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 141,665
- Date
- 17 Dec 2021
- Ownership
- Direct
LIXT
holding
Common Stock
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 1,333,333
- Date
- 17 Dec 2021
- Ownership
- As Trustee of the John and Barbara Kovach 2015 Trust
* marks a reported price that did not pass the local price check.